Ethifarmsp. z o.o. + limited partnership

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2008-04-23
Limited partner contribution
23,400.00 PLN
Activity description

Ethifarm manufactures medicines and dietary supplements. It operates a pharmaceutical production facility.

Registered address
Hiacyntowa 39, 60-175 Poznań, Poland
Website
ethifarm.pl
Electronic delivery address
AE:PL-38975-96392-SBAGD-14

Financials

Revenue history (in k)

From the notes

Profit allocationRetained in reserve capital

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 90 days late).

  • 202514/07/2026
  • 202430/06/2025
  • 202327/06/2024
  • 202230/06/2023
  • 202113/10/2022
  • 201929/09/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of pharmaceutical preparations66 / 184
Top 36%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations69 / 231
Top 30%
Sector · Manufacturing5,773 / 24,460
Top 24%
City · Poznań824 / 11,720
Top 7.0%
Voivodeship · Wielkopolskie3,315 / 30,901
Top 11%
Country · Poland29,876 / 297,873
Top 10%

Results vs industry

Revenue
This companyUSD 5.69mMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 202.86kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 5.30mMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 4.85mMedianUSD 897.46kAverageUSD 31.52m

Industry

Trademarks

Ethifarm holds 9 active trademarks registered with the Polish Patent Office. 17 marks have expired or were not registered. The first mark was filed in 2004.

MarkNumberClassesStatusProtected until
Pozkalium(word)Z.5316355Protected Jul 16, 2031
Slow Potas SR(word)Z.5316365Protected Jul 16, 2031
PERINDIL(word)Z.4586755, 35Protected Jul 5, 2036
NeuroDiab(word)Z.4404905Protected Mar 20, 2035
ZATOCAN forteZ.4166655Protected Jul 15, 2033
MarkProtected until
Pozkalium(word)Jul 16, 2031
Slow Potas SR(word)Jul 16, 2031
PERINDIL(word)Jul 5, 2036
NeuroDiab(word)Mar 20, 2035
ZATOCAN forteJul 15, 2033

Authorized Representatives

Joanna Eliza Namiota – Attorney-in-fact (sole)

Manner of representation

The general partner is authorized to represent the company.

Partners

Partners
Piotr Igor Czakłoszage 61
Ethifarm sp. z o.o.
Joanna Eliza Namiotaage 45
Krzysztof Robińskiage 66

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2008-05-12.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$150.2K
Buildings and premises
$1.5M

Public aid

15 public aid cases recorded, with a total value of $447,506.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$28,093
De minimis aid (in accordance with Commission Regulation 2023/2831)
$8,036
De minimis aid (in accordance with Commission Regulation 2023/2831)
$9,020

European Funds

ProjectEU co-financing
Strengthening the company’s innovation potential by developing the research and development department at Ethifarm Sp. z o.o. Sp. K.
$133.4K
Technological innovations for the manufacture of medicinal products as a path to the development of Ethifarm Sp. z o.o. Sp. K.
$48,696

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Exim Pharmasp. z o.o.
Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o.
Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A.
Biofaktorsp. z o.o.
Cefea sp. z o.o.sp. k.
MedicofarmaS.A.
Labofarmsp. z o.o.
Elanda Pharmasp. z o.o.
Actifarmsp. z o.o.
Przedsiębiorstwo Farmaceutyczne Sulphur Busko Zdrójsp. z o.o.

Change history

DateEvent
2016-03-10PKD change
2013-10-11PKD change
2008-04-23Entered in the register

FAQ

Last updated: 2026-07-14